Is LLY halal?
Eli Lilly
Eli Lilly (LLY) is included in the current HalalSignalz stock passlist as of May 7, 2026. This is an educational passlist snapshot, not a fatwa, personal financial advice, or a permanent status guarantee.
On HalalSignalz halal stock passlist
Screen: AAOIFI. Category: Healthcare - Big Pharma.
What does Eli Lilly do?
Eli Lilly develops and sells medicines for diabetes, obesity, oncology, immunology, neuroscience, and related chronic disease areas.
Halal strength
Positive
Technical
Neutral
Quarterly / fundamental
Neutral
Sentiment
Neutral
Ratings are conservative HalalSignalz snapshot labels from the checked-in passlist. Technical and sentiment labels default to Neutral unless the current snapshot has a stronger reason to flag Watch, Positive, or Weak.
Chart and Market Context
Review live candles, volume, and trend separately from the halal passlist verdict. A ticker can be on the passlist and still be poorly timed, overextended, illiquid, or too volatile for a given portfolio.
Company Fundamentals Snapshot
FMP fundamentals add business context for Eli Lilly; the HalalSignalz verdict above remains the main value of this page. Use these figures to sanity-check size, profitability, and quality before moving to chart timing or a paid signal.
FMP period: 2026 Q1, 2026-03-31.
- Quarterly revenue
- $19.80B
- Gross margin 81.9%.
- Quarterly net income
- $7.40B
- Net margin 37.4%.
- Market cap at data snapshot
- $822.73B
- P/E ratio
- 27.8x
- Diluted EPS 8.26 in the same filing period.
- Free cash flow yield
- 0.4%
- Return on equity
- 23.7%
- Current ratio 1.50.
Passlist Snapshot
- Business screen
- Passlist reviewed
- Healthcare - Big Pharma. Source: FMP checked-in deploy snapshot.
- Debt / market cap
- 5.3%
- $43.77B interest-bearing debt / $822.73B market cap.
- Cash / market cap
- 0.6%
- $5.29B cash and equivalents / $822.73B market cap.
- Reported interest income / revenue
- 0.0%
- $0 reported interest income / $19.80B revenue. Proxy only; this is not a full business-line impermissible revenue audit.
Halal Screening Notes
Healthcare - Big Pharma business activity reviewed as part of the current passlist.
What to Recheck Before Acting
LLY being present on this passlist only answers the first screening question. These are the next checks before treating Eli Lilly as investable for your own portfolio.
- Review the latest 10-Q or 10-K for Eli Lilly, especially debt, cash, and interest-income ratios.
- Confirm Eli Lilly's business mix still matches the screened category: Healthcare - Big Pharma.
- Check valuation, earnings trend, liquidity, and position size separately from the halal screen.
Related Healthcare - Big Pharma Research
Compare LLY with nearby passlist names so the halal screen, business activity, and timing context are not reviewed in isolation.
LLY Halal Screening FAQ
- Is LLY halal according to HalalSignalz?
- The current HalalSignalz verdict for LLY is: On HalalSignalz halal stock passlist. This May 7, 2026 stock passlist snapshot uses AAOIFI screening context.
- Does this stock page mean LLY is a buy?
- No. This page is an educational halal-screening snapshot for Eli Lilly; investors still need to review valuation, timing, liquidity, risk size, and their own scholar or advisor guidance.
- What should be checked before acting on LLY?
- Eli Lilly should be rechecked against fresh filings, business changes, market conditions, and any purification requirements before making an investment decision.